BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9206686)

  • 1. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
    Eichhorn R
    Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Child and adolescent hepatitis B vaccination--responsibilities of the public health service].
    Nassauer KA
    Gesundheitswesen; 1996 Nov; 58(11):616-7. PubMed ID: 9081503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
    Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [STIKO vaccinations should become an insurance covered responsibility. Better conditions for vaccinations? (interview by Dr. Beate Schumacher)].
    Lindlbauer-Eisenach U
    MMW Fortschr Med; 2006 Dec; 148(49-50):6. PubMed ID: 17619318
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of running a universal adolescent hepatitis B vaccination programme.
    Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
    Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of state policies on vaccine coverage by age 13 in an insured population.
    Olshen E; Mahon BE; Wang S; Woods ER
    J Adolesc Health; 2007 May; 40(5):405-11. PubMed ID: 17448397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Introduction of general hepatitis B vaccination in Switzerland].
    Zimmermann H; Vaudaux B; Kammerlander R
    Soz Praventivmed; 1998; 43 Suppl 1():S65-8, S138-42. PubMed ID: 9833270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
    Gervais A; Longuet P; Leport C
    Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B vaccine.
    John TJ
    Indian Pediatr; 1995 May; 32(5):609-13. PubMed ID: 8613328
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
    Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
    Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined prevention of hepatitis A and B].
    Fortschr Med; 1997 May; 115(13):18. PubMed ID: 9324474
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.